Evaluating Liposomal Bupivacaine with Rhomboid Intercostal Block for Pain Relief After Video-Assisted Thoracoscopic Surgery in Adults Aged 18 to 64
Led by Beijing Tiantan Hospital · Updated on 2026-03-06
134
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are investigating the use of liposomal bupivacaine combined with conventional bupivacaine in a rhomboid intercostal block RIB to manage postoperative pain in patients undergoing video-assisted thoracoscopic surgery VATS. VATS, a less invasive alternative to traditional thoracotomy, often leads to acute pain in over 80% of patients, which can cause complications and affect recovery. This study aims to evaluate and compare the effectiveness and safety of this novel anesthesia technique in a randomized controlled trial sponsored by Beijing Tiantan Hospital.
Participants will receive either an ultrasound-guided rhomboid intercostal block with standard bupivacaine or a combination of liposomal bupivacaine plus bupivacaine before surgery. The block is performed via Doppler ultrasound with a 22-gauge needle at the T5-T6 level near the scapula, injecting 20 mL of the assigned anesthetic solution into the rhomboid-intercostal fascial plane. Postoperatively, all patients will have access to patient-controlled analgesia PCA with sufentanil and ondansetron, with additional oral oxycodone-acetaminophen or intravenous morphine if needed for pain relief.
During the study, patients will be monitored for various outcomes including opioid use within 48 hours after surgery, pain scores at rest and during movement up to 3 months postoperatively, time to first analgesia request, sedation levels, recovery quality, length of hospital stay, and adverse events. Assessments occur frequently during the first 72 hours and at 1 week, 1 month, and 3 months after surgery. This comprehensive follow-up aims to measure both immediate and longer-term pain management and recovery, with study participation lasting up to three months post-surgery.
CONDITIONS
Brief Title
The Efficacy and Safety of Liposomal Bupivacaine for Rhomboid Intercostal Nerve Block in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery
Research Team
F
Fang Luo
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients scheduled for elective video-assisted thoracoscopic lobectomy or wedge resection under general anesthesia
Ages 18 to 64 years old
American Society of Anesthesiologists (ASA) physical status of I-III
Glasgow Coma Scale (GCS) score of 15
Ability to understand the trial and provide informed consent
You will not qualify if you...
History of chronic pain syndrome
Heart conduction block (sinus or atrioventricular block)
Unstable coronary artery disease
Gastric ulcer or gastric bleeding
Diabetes treated with insulin
Coagulation dysfunction or use of oral anticoagulants not stopped before surgery
Abnormal liver function (ALT/AST > 2x upper limit or bilirubin ≥ 1.5x upper limit)
Renal impairment or dialysis within 28 days before surgery
History of diagnosed mental illness or current psychotropic medication
Excessive alcohol or drug abuse, chronic opioid use, or painkiller use within 24 hours before surgery
Pregnancy or breastfeeding
Extreme body mass index (BMI < 15 or > 35)
Participation in another interventional trial affecting this study
Allergy to local anesthetics or study drugs used in this trial
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Perioperative period including surgery and immediate postoperative care
Participants undergo video-assisted thoracoscopic surgery with an ultrasound-guided rhomboid intercostal nerve block using either liposomal bupivacaine plus bupivacaine or bupivacaine hydrochloride prior to surgical incision. Postoperative pain is managed with a patient-controlled analgesia pump and rescue medications as needed.
1 surgical visit and hospital stay for approximately 48 hours
Follow-up
Duration - Up to 3 months postoperatively
Participants are assessed for pain relief, analgesic use, and recovery at multiple time points up to 3 months after surgery.
Visits at 2 hours, 24 hours, 48 hours, 72 hours, 1 week, 1 month, and 3 months postoperatively
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Effects of Low-Frequency Electrical Stimulation at Acupuncture Points on Pain Signals in Healthy Adults
Effects of Supervised Aerobic Exercise and Pain Neuroscience Education on Sensory, Musculoskeletal, and Psychosocial Factors in Women with Migraine Aged 18 to 48
Observing Factors That Affect Pain Medicine Use After Elective Surgery in Adults
Monitored in the Post-Anesthesia Care Unit
Effectiveness of Different Doses of Liposomal Bupivacaine in Nerve Block for Pain Relief After Robotic Total Knee Replacement Surgery
Study Comparing Two Pain Relief Methods During and After Total Knee Replacement Surgery
Evaluating Ultrasound-Guided Deep Iliacus Plane Block for Pain Relief After Hip Fracture Surgery in Adults
Comparing Anterior Iliopsoas Space Block and PENG Block for Easier Spinal Anesthesia Positioning in Hip Surgery Patients
Comparing Ultrasound-Guided Nerve Blocks for Pain Relief and Breathing Safety in Shoulder Surgery
Long-Term Effects of Serratus Anterior Plane Block SAPB Versus Standard Pain Relief in Adults with Multiple Unilateral Rib Fractures
Home-Based Clinical Assessment by Municipal Acute Care Teams with Remote Physician Consultation
Compared to Standard Care to Reduce Hospital Admissions Among Nursing Home Residents
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Comparison of Rhomboid Intercostal Block, Erector Spinae Plane Block, and Serratus Plane Block on Analgesia for Video-Assisted Thoracic Surgery: A Prospective, Randomized, Controlled Trial.